Publication | Open Access

Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial

Randomized Clinical TrialPsychiatryPsychotic DisorderAddictionPsychotropic MedicationPharmacologyPsychopharmacologySchizophreniaAddiction MedicineSocial SciencesPharmacotherapyRelapse PreventionMedicineRisperidone Long-acting InjectablePsychopathology